Darigabat and subtype-selective GABA-A modulation: pharmacology, clinical development, and translational challenges
{{output}}
Introduction: Darigabat is a selective γ-aminobutyric acid type A (GABA-A) receptor positive allosteric modulator targeting α2, α3, and α5 subunits, developed to preserve anxiolytic and anticonvulsant effects while reducing ... ...
